Log In
Print this Print this

Resunab (JBT-101)

  Manage Alerts
Collapse Summary General Information
Company Corbus Pharmaceuticals Holdings Inc.
DescriptionSynthetic cannabinoid CB2 receptor (CNR2) agonist
Molecular Target Cannabinoid CB2 receptor (CNR2)
Mechanism of ActionCannabinoid CB2 receptor agonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today